Начало・Списък с акции・Quanterix Corp

Quanterix Corp

Затворен

СекторЗдравеопазване

3.82 2.14

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

3.7

Максимум

3.86

Ключови измерители
By Trading Economics
Приходи	5.6M -18M
Продажби	-7.4M 36M
EPS	0.16
Марж на печалбата	-48.17
Служители	450
EBITDA	5.5M -11M

Препоръки
By TipRanks
Препоръки	Неутрален
12-месечна прогноза	+6.38% upside

Дивиденти
By Acuity
Следващи печалби	10.08.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	16M 175M
Предишно отваряне	1.68
Предишно затваряне	3.82

Настроения в новините

By Acuity

50%

156 / 340 Класиране в Healthcare

Quanterix Corp Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

5.08.2026 г., 19:23 ч. UTC

Quanterix Corp shares are higher, supported by a broader rise in the Life Sciences Tools & Services sector. The stock remains below its 20-day moving average.

3.08.2026 г., 19:26 ч. UTC

Quanterix Corp shares are higher today, tracking broader market gains amid rising confidence in tech stocks and falling energy prices.

31.07.2026 г., 19:46 ч. UTC

Quanterix Corp shares are higher today, reflecting a modest gain since Thursday's close. The stock is near the lower end of its one-month range.

30.07.2026 г., 19:59 ч. UTC

Quanterix Corp is trading higher amid a broader recovery in tech shares. The asset has shown notable volatility, pulling back from earlier session highs.

29.07.2026 г., 19:43 ч. UTC

Macro Event

Quanterix Corp's shares are lower today amid broader market declines, reflecting heightened volatility following the Federal Reserve's decision to maintain interest rates.

28.07.2026 г., 20:06 ч. UTC

Quanterix Corp shares are declining amid broader market weakness, with the Nikkei 225 dropping significantly due to concerns over AI spending and semiconductor competition.

27.07.2026 г., 16:06 ч. UTC

Quanterix Corp shares are higher today, following a strong opening. No specific news was identified to explain the price movement.

24.07.2026 г., 19:53 ч. UTC

Quanterix Corp shares are lower today, continuing a decline since Thursday amid broader market uncertainty from oil volatility and new U.S. tariffs.

22.07.2026 г., 19:36 ч. UTC

Quanterix Corp shares are lower in Wednesday's session, continuing a decline since Tuesday's close amid rising crude oil prices and market concerns.

21.07.2026 г., 21:26 ч. UTC

Quanterix Corp shares are higher in after-market hours, reflecting positive trading momentum. Broader market strength may be influencing sentiment following the close.

20.07.2026 г., 19:46 ч. UTC

Quanterix Corp shares are higher today amid positive market sentiment and a notable rise in the Hang Seng 50 Index, despite no specific company news.

Сравнение с други в отрасъла

Ценова промяна

Quanterix Corp Прогноза

Ценова цел

By TipRanks

6.38% нагоре

12-месечна прогноза

Среден 4 USD 6.38%

Висок 4 USD

Нисък 4 USD

Според 1 анализатори от Wall Street, предложили 12-месечна ценова цел за Quanterix Corp през последните три месеца.

Консенсусна оценка

By TipRanks

Неутрален

1 ratings

Купи

Задържане

Продай

Според 1 анализатори, дали борсови рейтинги на Quanterix Corp през последните 3 месеца.

Настроение

By Acuity

156 / 340 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Quanterix Corp

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, it offers contract research services, including sample testing, homebrew assay development, custom assay development, lucent diagnostic, and LDT testing services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.